Joinn Laboratories China Co Ltd

Price Chart

Risk-Adjusted Performance

Joinn Laboratories China Co Ltd (6127) Price Performance

Joinn Laboratories China Co Ltd (6127) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at HKD16.50, down 3.57% from the previous close.

Over the past year, 6127 has traded between a low of HKD9.62 and a high of HKD27.95. The stock has gained 11.4% over this period. It is currently 41.0% below its 52-week high.

Joinn Laboratories China Co Ltd has a market capitalization of $28.28B, with a price-to-earnings ratio of 98.18 and a dividend yield of 0.15%.

About Joinn Laboratories China Co Ltd

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.